A multiplex tissue immunoblotting assay for proteomic profiling: A pilot study of the normal to tumor transition of esophageal squamous cell carcinoma

Cancer Epidemiology Biomarkers and Prevention

Volumn 15, Issue 7, 2006, Pages 1403-1408

  Chung, Joon Yong ^a,b   Braunschweig, Till ^a   Hu, Nan ^a   Roth, Mark ^a   Traicoff, June L ^c   Wang, Quan Hong ^d   Knezevic, Vladimir ^c,e   Taylor, Philip R ^a   Hewitt, Stephen M ^a,f  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Inje University College of Medicine   (South Korea)

^c 20/20 Gene Systems   (United States)

^d SHANXI CANCER HOSPITAL   (China)

^e Constella Group Inc ^*  (United States)

^f Advanced Technology Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; CYTOKERATIN 14; CYTOKERATIN 4; LIPOCORTIN 1; OSTEONECTIN; PROTEIN P53;

ARTICLE; CANCER INVASION; CARCINOGENESIS; CONTROLLED STUDY; DYSPLASIA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOCHEMISTRY; INVASIVE CARCINOMA; PILOT STUDY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; STROMA;

CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOBLOTTING; KERATINS; MOLECULAR DIAGNOSTIC TECHNIQUES; NEOPLASM INVASIVENESS; OSTEONECTIN; PILOT PROJECTS; PRECANCEROUS CONDITIONS; PROTEOME; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33746467991     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-05-0651     Document Type: Article

References (23)

1. Greenlee RT, Hill-Harmon M, Murray T, Thun M. Cancer statistics, 2001. CA Cancer J Clin 2001;51:15-36.
2. Hu YC, Lam KY, Law S, Wong J, Srivastava G. Profiling of differentially expressed cancer-related genes in esophageal squamous cell carcinoma (ESCC) using human cancer cDNA arrays: overexpression of oncogenes MET correlates with tumor differentiation in ESCC. Clin Cancer Res 2001;7:3519-25.
3. Selaru FM, Zou T, Xu Y, et al. Global gene expression profiling in Barrett's esophagus and esophageal cancer: a comparative analysis using cDNA microarrays. Oncogene 2002;21:475-8.
4. Xu Y, Selaru FM, Yin J, et al. Artificial neural networks and gene filtering distinguish between global gene expression profiles of Barrett's esophagus and esophageal cancer. Cancer Res 2002;62:3493-7.
5. Su H, Hu N, Shih J, et al. Gene expression analysis of esophageal squamous cell carcinoma reveals consistent molecular profiles related to a family history of upper gastrointestinal cancer. Cancer Res 2003;63:3872-6.
6. Kan T, Shimada Y, Sato F, et al. Gene expression profiling in human esophageal cancers using cDNA microarray. Biochem Biophys Res Commun 2001;286:792-801.
7. McManus DT, Olaru A, Meltzer SJ. Biomarkers of esophageal adenocarcinoma and Barrett's esophagus. Cancer Res 2004;64:1561-9.
8. Chung JY, Braunschweig T, Baibakov G, et al. Transfer and multiplex immunoblotting of a paraffin embedded tissue. Proteomics 2006;6:767-74.
9. Chu PG, Lyda MH, Weiss LM. Cytokeratin 14 expression in epithelial neoplasms: a survey of 435 cases with emphasis on its value in differentiating squamous cell carcinomas from other epithelial tumours. Histopathology 2001;39:9-16.
10. Paweletz CP, Ornstein DK, Roth MJ, et al. Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma. Cancer Res 2000;60:6293-7.
11. Fang MZ, Liu C, Song Y, et al. Over-expression of gastrin-releasing peptide in human esophageal squamous cell carcinomas. Carcinogenesis 2004;25:865-71.
12. Xia SH, Hu LP, Hu H, et al. Three isoforms of annexin I are preferentially expressed in normal esophageal epithelia but down-regulated in esophageal squamous cell carcinomas. Oncogene 2002;21:6641-8.
13. Shamma A, Yamamoto H, Doki Y, et al. Up-regulation of cyclooxygenase-2 in squamous carcinogenesis of the esophagus. Clin Cancer Res 2000;6:1229-38.
14. Keller JJ, Giardiello FM. Chemoprevention strategies using NSAIDs and COX-2 inhibitors. Cancer Biol Ther 2003;2:S140-9.
15. Tatsuguchi A, Matsui K, Shinji Y, et al. Cyclooxygenase-2 expression correlates with angiogenesis and apoptosis in gastric cancer tissue. Hum Pathol 2004;35:488-95.
16. Younes M, Lebovitz RM, Lechago LV, Lechago J. p53 protein accumulation in Barrett's metaplasia, dysplasia, and carcinoma: a follow-up study. Gastroenterology 1993;105:1637-42.
17. Geboes K, van Eyken P. The diagnosis of dysplasia and malignancy in Barrett's oesophagus. Histopathology 2000;37:99-107.
18. Wang LD, Hong JY, Qiu SL, Gao H, Yang CS. Accumulation of p53 protein in human esophageal precancerous lesions: a possible early biomarker for carcinogenesis. Cancer Res 1993;53:1783-7.
19. Hu N, Huang J, Emmert-Buck MR, et al. Frequent inactivation of the TP53 gene in esophageal squamous cell carcinoma from a high-risk population in China. Clin Cancer Res 2001;7:883-91.
20. Brekken RA, Puolakkainen P, Graves DC, Workman G, Lubkin SR, Sage EH. Enhanced growth of tumors in SPARC null mice is associated with changes in the ECM. J Clin Invest 2003;111:487-95.
21. Tartare-Deckert S, Chavey C, Monthouel MN, Gautier N, Van Obberghen E. The matricellular protein SPARC/osteonectin as a newly identified factor up-regulated in obesity. J Biol Chem 2001;276:22231-7.
22. Cole AR, Ji H, Simpson RJ. Proteomic analysis of colonic crypts from normal, multiple intestinal neoplasia and p53-null mice: a comparison with colonic polyps. Electrophoresis 2002;21:772-81.
23. Hewitt SM, Dear J, Star RA. Discovery of protein biomarkers for renal diseases. J Am Soc Nephrol 2004;15:1677-89.